SWOG clinical trial number
SWOG-8514

Randomized Comparison of Cisplatin + 5-Fluorouracil Versus CBDCA + 5-Fluorouracil Versus Methotrexate In Advanced Squamous Cell Carcinoma of the Head and Neck, Phase III

Closed
Phase
Published
Abbreviated Title
Randomized Comparison of Cisplatin + 5-Fluorouracil Versus CBDCA + 5-Fluorouracil Versus Methotrexate In Advanced Squamous Cell Carcinoma of the Head and Neck, Phase III
Activated
01/03/1985
Closed
03/01/1989

Publication Information Expand/Collapse

1992

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil vs methotrexate in advanced squamous cell carcinoma of the head & neck: A Southwest Oncology Group study.

AA Forastiere;B Metch;DE Schuller;JF Ensley;LF Hutchins;SP Balcerzak;JA Kish;S McClure;E VonFeldt;SK Williamson;DD Von Hoff JCO 10(8):1245-1251

1989

Randomized comparison of cisplatin (CDDP) + 5-fluorouracil (5-FU)vs. carboplatin (CBP) + 5-FU vs. methotrexate (MTX) in advanced squamouscell carcinoma of the head and neck.

A Forastiere;B Metch;M Keppen;D Schuller;J Ensley;C Coltman, Jr ASCO 8:168(#655)